Verena Meraner

901 total citations
25 papers, 701 citations indexed

About

Verena Meraner is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Genetics. According to data from OpenAlex, Verena Meraner has authored 25 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 10 papers in Pediatrics, Perinatology and Child Health and 6 papers in Genetics. Recurrent topics in Verena Meraner's work include Cancer survivorship and care (13 papers), Childhood Cancer Survivors' Quality of Life (8 papers) and Estrogen and related hormone effects (5 papers). Verena Meraner is often cited by papers focused on Cancer survivorship and care (13 papers), Childhood Cancer Survivors' Quality of Life (8 papers) and Estrogen and related hormone effects (5 papers). Verena Meraner collaborates with scholars based in Austria, United Kingdom and Germany. Verena Meraner's co-authors include Barbara Sperner‐Unterweger, Bernhard Holzner, Georg Kemmler, Martin Kopp, Michael Hubalek, Anne Oberguggenberger, Monika Sztankay, Eva‐Maria Gamper, Johannes M. Giesinger and W. Wolfgang Fleischhacker and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Verena Meraner

24 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Verena Meraner Austria 15 403 181 131 103 91 25 701
Anne Oberguggenberger Austria 18 439 1.1× 179 1.0× 151 1.2× 186 1.8× 83 0.9× 43 1.0k
Sarah Dauchy France 15 451 1.1× 165 0.9× 206 1.6× 131 1.3× 120 1.3× 71 912
Dounya Schoormans Netherlands 16 316 0.8× 112 0.6× 173 1.3× 72 0.7× 67 0.7× 47 765
Kate Webber Australia 15 404 1.0× 136 0.8× 136 1.0× 88 0.9× 68 0.7× 47 669
Carolina Núñez-Valencia Mexico 4 304 0.8× 99 0.5× 127 1.0× 86 0.8× 62 0.7× 5 595
D. Storey United Kingdom 12 541 1.3× 201 1.1× 171 1.3× 143 1.4× 81 0.9× 22 858
Eline H. van Roekel Netherlands 18 497 1.2× 171 0.9× 136 1.0× 153 1.5× 23 0.3× 50 887
Fausto Roila Italy 15 336 0.8× 176 1.0× 176 1.3× 135 1.3× 29 0.3× 44 800
Frances Cartwright United States 15 370 0.9× 180 1.0× 211 1.6× 54 0.5× 40 0.4× 35 659
Marisol Hernandez United States 10 448 1.1× 82 0.5× 85 0.6× 109 1.1× 69 0.8× 24 891

Countries citing papers authored by Verena Meraner

Since Specialization
Citations

This map shows the geographic impact of Verena Meraner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Meraner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Meraner more than expected).

Fields of papers citing papers by Verena Meraner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verena Meraner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Meraner. The network helps show where Verena Meraner may publish in the future.

Co-authorship network of co-authors of Verena Meraner

This figure shows the co-authorship network connecting the top 25 collaborators of Verena Meraner. A scholar is included among the top collaborators of Verena Meraner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verena Meraner. Verena Meraner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Loth, Fanny L., Verena Meraner, Bernhard Holzner, et al.. (2018). Following patient pathways to psycho‐oncological treatment: Identification of treatment needs by clinical staff and electronic screening. Psycho-Oncology. 27(4). 1312–1319. 7 indexed citations
2.
Oberguggenberger, Anne, Caroline Martini, Lesley Fallowfield, et al.. (2017). Self-reported sexual health: Breast cancer survivors compared to women from the general population – an observational study. BMC Cancer. 17(1). 599–599. 53 indexed citations
3.
Oberguggenberger, Anne, Verena Meraner, Monika Sztankay, et al.. (2017). Health Behavior and Quality of Life Outcome in Breast Cancer Survivors: Prevalence Rates and Predictors. Clinical Breast Cancer. 18(1). 38–44. 25 indexed citations
4.
Oberguggenberger, Anne, Verena Meraner, Monika Sztankay, et al.. (2017). Can we use gonadotropin plasma concentration as surrogate marker for BMI-related incomplete estrogen suppression in breast cancer patients receiving anastrozole?. BMC Cancer. 17(1). 226–226. 3 indexed citations
5.
Oberguggenberger, Anne, Monika Sztankay, Raphael J. Morscher, et al.. (2016). Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study. Journal of Psychosomatic Research. 89. 39–45. 13 indexed citations
6.
Meraner, Verena & Barbara Sperner‐Unterweger. (2016). Patienten, Ärzte und Pflegepersonal auf Intensivstationen. Der Nervenarzt. 87(3). 264–268. 5 indexed citations
7.
Hüfner, Katharina, Anne Oberguggenberger, Cláudia Adriana Kohl, et al.. (2015). Levels in neurotransmitter precursor amino acids correlate with mental health in patients with breast cancer. Psychoneuroendocrinology. 60. 28–38. 32 indexed citations
8.
Hubalek, Michael, Anne Oberguggenberger, Beate Beer, et al.. (2014). Does Obesity Interfere With Anastrozole Treatment? Positive Association Between Body Mass Index and Anastrozole Plasma Levels. Clinical Breast Cancer. 14(4). 291–296. 11 indexed citations
9.
Wintner, Lisa M., Johannes M. Giesinger, August Zabernigg, et al.. (2013). Quality of life during chemotherapy in lung cancer patients: results across different treatment lines. British Journal of Cancer. 109(9). 2301–2308. 62 indexed citations
10.
Meraner, Verena, Eva‐Maria Gamper, Johannes M. Giesinger, et al.. (2012). Monitoring physical and psychosocial symptom trajectories in ovarian cancer patients receiving chemotherapy. BMC Cancer. 12(1). 77–77. 48 indexed citations
11.
Oberguggenberger, Anne, Monika Sztankay, Beate Beer, et al.. (2012). Adherence evaluation of endocrine treatment in breast cancer: methodological aspects. BMC Cancer. 12(1). 474–474. 32 indexed citations
12.
Egle, Daniel, Anne Oberguggenberger, Monika Sztankay, et al.. (2011). Do obese women benefit less from adjuvant endocrine therapy with aromatase inhibitors? Preliminary analysis on the association of BMI and aromatase inhibitor plasma levels.. Journal of Clinical Oncology. 29(15_suppl). e11118–e11118. 2 indexed citations
13.
Beer, Beate, Birthe Schubert, Anne Oberguggenberger, et al.. (2010). Development and validation of a liquid chromatography–tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study. Analytical and Bioanalytical Chemistry. 398(4). 1791–1800. 46 indexed citations
14.
Sperner‐Unterweger, Barbara, Gabriele Neurauter, Martin Klieber, et al.. (2010). Enhanced tryptophan degradation in patients with ovarian carcinoma correlates with several serum soluble immune activation markers. Immunobiology. 216(3). 296–301. 45 indexed citations
15.
Beer, Beate, B. Schubert, Anne Oberguggenberger, et al.. (2010). 37 A validated analytical method for the simultaneous quantification of tamoxifen, endoxifen, anastrozole and letrozole. European Journal of Cancer Supplements. 8(3). 69–69. 4 indexed citations
16.
Giesinger, Johannes M., Georg Kemmler, Verena Meraner, et al.. (2009). Towards the Implementation of Quality of Life Monitoring in Daily Clinical Routine: Methodological Issues and Clinical Implication. Breast Care. 4(3). 148–154. 14 indexed citations
17.
Meraner, Verena, Johannes M. Giesinger, Georg Kemmler, et al.. (2009). Development of a screening tool for the identification of psychooncological treatment need in breast cancer patients. Psycho-Oncology. 18(9). 974–983. 24 indexed citations
18.
Kopp, Martin, Bernhard Holzner, Verena Meraner, et al.. (2005). Quality of life in adult hematopoietic cell transplant patients at least 5 yr after treatment: a comparison with healthy controls. European Journal Of Haematology. 74(4). 304–308. 45 indexed citations
19.
Holzner, Bernhard, Georg Kemmler, David Cella, et al.. (2004). Normative data for functional assessment of cancer therapy General scale and its use for the interpretation of quality of life scores in cancer survivors. Acta Oncologica. 43(2). 153–160. 105 indexed citations
20.
Holzner, Bernhard, Georg Kemmler, Verena Meraner, et al.. (2003). Fatigue in ovarian carcinoma patients. Cancer. 97(6). 1564–1572. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Oberguggenberger Breakdown of academic impact, for papers by Sarah Dauchy Breakdown of academic impact, for papers by Dounya Schoormans Breakdown of academic impact, for papers by Kate Webber Breakdown of academic impact, for papers by Carolina Núñez-Valencia Breakdown of academic impact, for papers by D. Storey Breakdown of academic impact, for papers by Eline H. van Roekel Breakdown of academic impact, for papers by Fausto Roila Breakdown of academic impact, for papers by Frances Cartwright Breakdown of academic impact, for papers by Marisol Hernandez
Rankless by CCL
2026